July 20 (Reuters) - Australia's competition watchdog on Thursday raised concerns over Australian Clinical Labs' (ACL) A$1.52 billion ($1.03 billion) buyout offer for medical centre operator Healius (HLS) , who had rejected the proposal in May.
The Australian Competition and Consumer Commission said the acquisition would lessen competition in the Australian pathology services markets.
($1 = 1.4775 Australian dollars)
News: HLS Regulator flags concerns on Australian Clinical's buyout offer for Healius
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.060(3.59%) |
Mkt cap ! $1.169B | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.68 | $1.61 | $8.901M | 5.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 125840 | 6 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| HLS (ASX) Chart |